Women who use Depo-Provera face a higher risk of developing a slow-growing brain tumor, known as a meningioma, while the ...

Pfizer Inc. (NYSE: PFE) faces mounting legal challenges over claims that its contraceptive injection Depo-Provera (DMPA) is linked to brain tumors, with a key court hearing set for late September that ...

A study found women who used the contraceptive injection for at least a year are 5.6 times more likely to develop meningioma ...

For decades, millions of women have relied on the Depo-Provera birth control shot as a convenient form of long-term contraception. However, growing medical evidence has linked long-term Depo-Provera ...

Elizabeth Fleurisma tears up as she runs her fingers over the scars that map her scalp. The Long Island mom was stunned to discover at the age of 30 that she had a brain tumor the size of a lime. She ...

THOUSANDS of women who opt for four common contraceptives over other forms of birth control may be at higher risk of brain ...

MINNEAPOLIS, Jan. 15, 2025 /PRNewswire/ -- National personal injury law firm Pritzker Hageman has assembled an all-female legal team to pursue litigation on behalf of women who developed meningioma ...

The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...

The FDA approved a label change for Pfizer’s birth control injection Depo-Provera on Dec. 13, adding a warning about the risk of meningioma — a brain tumor — to two versions of the drug. The update ...